CN109020864B - Application of metal hydride/palladium compound catalytic reduction system in reduction of alkenyl active methylene compound and reduction method - Google Patents
Application of metal hydride/palladium compound catalytic reduction system in reduction of alkenyl active methylene compound and reduction method Download PDFInfo
- Publication number
- CN109020864B CN109020864B CN201811064127.4A CN201811064127A CN109020864B CN 109020864 B CN109020864 B CN 109020864B CN 201811064127 A CN201811064127 A CN 201811064127A CN 109020864 B CN109020864 B CN 109020864B
- Authority
- CN
- China
- Prior art keywords
- reduction
- compound
- active methylene
- palladium
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/04—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing carboxylic acids or their salts
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/12—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing organo-metallic compounds or metal hydrides
- B01J31/121—Metal hydrides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
- B01J31/1805—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2204—Organic complexes the ligands containing oxygen or sulfur as complexing atoms
- B01J31/2208—Oxygen, e.g. acetylacetonates
- B01J31/2226—Anionic ligands, i.e. the overall ligand carries at least one formal negative charge
- B01J31/223—At least two oxygen atoms present in one at least bidentate or bridging ligand
- B01J31/2239—Bridging ligands, e.g. OAc in Cr2(OAc)4, Pt4(OAc)8 or dicarboxylate ligands
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
- B01J31/2442—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising condensed ring systems
- B01J31/2447—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising condensed ring systems and phosphine-P atoms as substituents on a ring of the condensed system or on a further attached ring
- B01J31/2452—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising condensed ring systems and phosphine-P atoms as substituents on a ring of the condensed system or on a further attached ring with more than one complexing phosphine-P atom
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/26—Catalysts comprising hydrides, coordination complexes or organic compounds containing in addition, inorganic metal compounds not provided for in groups B01J31/02 - B01J31/24
- B01J31/28—Catalysts comprising hydrides, coordination complexes or organic compounds containing in addition, inorganic metal compounds not provided for in groups B01J31/02 - B01J31/24 of the platinum group metals, iron group metals or copper
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/26—Catalysts comprising hydrides, coordination complexes or organic compounds containing in addition, inorganic metal compounds not provided for in groups B01J31/02 - B01J31/24
- B01J31/28—Catalysts comprising hydrides, coordination complexes or organic compounds containing in addition, inorganic metal compounds not provided for in groups B01J31/02 - B01J31/24 of the platinum group metals, iron group metals or copper
- B01J31/30—Halides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Abstract
The invention discloses an application of a metal hydride/palladium compound catalytic reduction system in reduction of an alkenyl active methylene compound and a reduction method. The reduction system of the invention is a simple method for reducing alkenyl active methylene compounds, the used hydride and palladium compound catalysts are all reagents which are easily obtained in a laboratory, and compared with a common hydrogen hydrogenation method and a reducing agent reduction method, the method is easier to operate, higher in safety, mild in condition, high in reaction yield, capable of performing two-step reaction in one pot, and high in atom economy and step economy.
Description
Technical Field
The invention belongs to the technical field of organic synthesis, and particularly relates to application of a metal hydride/palladium compound catalytic system in reduction and one-pot reaction of an alkenyl active methylene compound.
Background
Sodium hydride is a strong base which is frequently used in laboratories and industry, and for a long time, there are few reports on the use of sodium hydride as a reducing agent, and the existing reaction requires a large excess of reducing agent (3 equivalents) and at least 2 equivalents of sodium iodide as a promoter. The reduction of alkenyl-activated methylene compounds is a common chemical transformation to produce the corresponding monoalkyl-substituted activated methylene compounds; such reactions are typically reduced using hydrogen/palladium on carbon conditions; in addition, some hydrogen-negative agents, such as [ (Ph)3P)CuH]6 (Stryker reagent), R3SiH, Hantzsch esters, etc. can also accomplish this reduction of electron deficient double bonds. However, these reduction conditions are either hazardous, for exampleExplosive hydrogen; or the reagents are expensive, the reaction lacks atom economy and more waste needs to be disposed of after the reaction, such as [ (Ph)3P)CuH]6 (Stryker reagent), R3SiH, Hantzsch ester, etc., or some of them have limitations in industrial application because they require treatment of a large amount of wastewater after reaction.
Disclosure of Invention
The technical problem to be solved by the invention is to provide an application of a metal hydride/palladium compound catalytic reduction system, thereby providing a new method for reducing an alkenyl active methylene compound and an application of the method in a one-pot reaction.
The technical means of the invention for reducing the alkenyl active methylene compound is to take metal hydride as a reducing agent and palladium and salts thereof as catalysts to react in a solvent to obtain a double-bond reduced product. The specific technical scheme is as follows:
the application of a metal hydride/palladium compound catalytic reduction system in the reduction of alkenyl active methylene compounds.
The reduction method of the alkenyl active methylene compound comprises the steps of taking the alkenyl active methylene compound as a substrate, taking metal hydride as a reducing agent and taking a palladium compound as a catalyst, carrying out reduction reaction to obtain a reduction product, and finishing the reduction of the alkenyl active methylene compound.
In the technical scheme, after the reduction reaction, saturated ammonium chloride aqueous solution is added to stop the reaction, and then the reduction product is obtained through extraction, drying, rotary evaporation and column chromatography purification.
In the present invention, the chemical structural formula of the alkenyl activated methylene compound is as follows:
wherein R is1、R2Independently selected from hydrogen, alkyl, phenyl, substituted phenyl, naphthyl, pyridyl and quinolyl.
In the chemical structural formula of the alkenyl active methylene compound, alkyl can be methyl, and substituted phenyl can be halogen substituted phenyl or methoxy substituted phenyl.
In the present invention, the metal hydride includes sodium hydride, lithium hydride, potassium hydride, calcium hydride, preferably sodium hydride, lithium hydride, more preferably sodium hydride; the palladium compound comprises palladium chloride, palladium acetate, Pd (MeCN)2Cl2、[(η3-C3H5)PdCl]2、Pd(TFA)2、Pd(dppp)Cl2、Pd2(dba)3、Pd(C6H5CN)2Cl2、Pd(OH)2、Pd/C、Pd(PPh3)4、Pd(PPh3)2Cl2Palladium chloride and palladium acetate are preferred, and palladium chloride is more preferred.
In the invention, the molar ratio of the palladium compound, the metal hydride and the alkenyl active methylene compound is (0.01-1): (1-5): 1, preferably (0.03-0.1): (1-3): 1, more preferably 0.05: (1.5-2.5): 1, and most preferably 0.05: 2: 1.
In the invention, the reduction of the alkenyl active methylene compound is carried out in a solvent under the atmosphere of nitrogen; the solvent includes DMA (N, N-dimethylacetamide), DMF, THF, DME, or dioxane.
In the invention, the reduction temperature of the alkenyl active methylene compound is-50-120 ℃, preferably 0-50 ℃, and more preferably room temperature; the reduction time is 0.3 to 10 hours, preferably 0.4 to 5 hours, and more preferably 0.5 hour.
The sodium hydride/palladium reduced alkenyl active methylene compound has the following advantages: 1) compared with sodium borohydride, sodium hydride is cheaper (sodium borohydride is industrially prepared by taking sodium hydride as a raw material); compared with hydrogen/palladium carbon reduction, the sodium hydride method has higher safety; 2) the sodium hydride has small molecular weight, simple composition and small using amount in the reaction, so the method using the sodium hydride as the reducing agent is an atom economic method; the byproducts are harmless sodium salts, and no other waste is generated; 3) the product of the alkenyl active methylene compound reduced by sodium hydride is sodium salt before post-treatment, which is different from the prior reduction method, and the sodium salt with reactivity can continuously react with an electrophilic reagent to obtain a disubstituted product, thereby expanding the application of the alkenyl active methylene compound. In the one-pot reaction, the reducibility and the alkalinity of the sodium hydride are fully utilized, the atom economy and the step economy of the reaction are greatly improved, and the reaction cost is reduced.
The technical scheme of the invention can be specifically as follows: under the protection of nitrogen, suspending a palladium compound and a metal hydride in a solvent, stirring, adding a substrate alkenyl active methylene compound, reacting at-50 ℃ to 120 ℃ for 0.3-10 hours, adding a saturated ammonium chloride aqueous solution to stop the reaction, extracting with the solvent, evaporating to dryness, and purifying by column chromatography to obtain a product.
The reduction of alkenyl-activated methylene compounds is a chemical reaction often used in organic synthesis, and generally two types of methods are adopted: one is hydrogenation reduction using hydrogen/palladium carbon, in the process, the use of hydrogen is a potential hazard factor, and improper operation can cause fire and explosion; the other is reduction using a reducing agent, which is expensive and requires treatment of large amounts of wastewater. The invention has important significance in using the relatively safe and low-cost metal hydride to replace hydrogen and a reducing agent for the reduction of the alkenyl active methylene compound; and more importantly, the method fully utilizes the reducibility and alkalinity of the sodium hydride and can carry out one-pot reaction.
The reduction system of the invention is a simple method for reducing alkenyl active methylene compounds, the used hydride and palladium compound catalysts are all reagents which are easily obtained in a laboratory, and compared with a common hydrogen hydrogenation method and a reducing agent reduction method, the method is easier to operate, higher in safety, mild in condition, high in reaction yield, capable of performing two-step reaction in one pot, and high in atom economy and step economy.
Detailed Description
Example 1
Palladium chloride (1.7 mg, 0.01 mmol, 5 mol%) and sodium hydride (60% in oil, 16 mg, 0.4 mmol, 2 equiv) were suspended in DMA (1.0 mL) under nitrogen, stirred at room temperature for 5 minutes, a solution of compound 1a (0.2 mmol) in DMA (0.5 mL) was added, then reacted at room temperature for 30 minutes, saturated aqueous ammonium chloride was added to quench the reaction, extracted with ethyl acetate, the combined extracts were dried over sodium sulfate, evaporated to dryness by rotary evaporation, and purified by column chromatography to give product 2a in 99% yield.1H NMR (400 MHz, CDCl3): δ 7.48 (t, J = 7.6 Hz, 2H), 7.38 (t, J = 7.3 Hz, 1H), 7.25-7.17 (m, 5H), 7.17-7.10 (m, 3H), 7.02-6.93 (m, 2H), 6.64 (d, J = 7.8 Hz, 1H), 3.95-3.88 (m, 1H), 3.52 (dd, J = 13.5, 4.2 Hz, 1H), 3.17 (dd, J= 13.5, 8.2 Hz, 1H). 13C NMR (151 MHz, CDCl3): δ 176.56, 144.51, 137.40, 134.57, 129.71, 128.31, 128.23, 128.18, 127.99, 126.83, 126.78, 124.83, 122.63, 47.36, 37.26. LR-MS (ESI): m/z 300.2 [M+H]+。
Under the protection of nitrogen, palladium chloride (1.7 mg, 0.01 mmol, 5 mol%) and sodium hydride (60% in oil, 16 mg, 0.4 mmol, 2 equiv) are suspended in DMA (1.0 mL), the mixture is stirred at room temperature for 5 minutes, a solution of the compound 1a (0.2 mmol) in the DMA (0.5 mL) is added, then the mixture is reacted at room temperature for 30 minutes, benzyl bromide (1.5 eq.) is added, the reaction is continuously stirred, after the reaction of the raw materials is finished, a saturated ammonium chloride aqueous solution is added to quench the reaction, the reaction is extracted by ethyl acetate, an organic phase is collected, a crude product is obtained by spin-drying a solvent, and column chromatography is carried out, so that the compound 3a is finally obtained, and the yield is 98%.1H NMR (400 MHz, CDCl3): δ 7.38-7.27 (m, 4H), 7.13-7.04 (m, 7H), 7.02-6.94 (m, 5H), 6.64 (d, J = 7.3 Hz, 2H), 6.21 (d, J = 7.7 Hz, 1H), 3.47 (d, J = 12.9 Hz, 2H), 3.25 (d, J = 12.9 Hz, 2H). 13C NMR (151 MHz, CDCl3): δ 177.80, 144.12, 136.08, 134.37, 130.26, 130.14, 129.49, 128.06, 127.85, 127.76, 126.81, 126.65, 124.42, 122.23, 108.88, 56.67, 43.83. LR-MS (ESI): m/z 390.3 [M+H]+。
Example 2
Palladium acetate (2.2 mg, 0.01 mmol, 5 mol%) and lithium hydride (4.8 mg, 0.6 mmol, 3.0 equiv) were suspended in DMF (1.0 mL) under nitrogen, stirred at room temperature for 5 minutes, a solution of compound 1a (0.2 mmol) in DMF (0.5 mL) was added, then reacted at 120 ℃ for 0.5 hour, saturated aqueous ammonium chloride was added to stop the reaction, extracted with ethyl acetate, the combined extracts were dried over sodium sulfate, evaporated to dryness by rotary evaporation, and purified by column chromatography to give product 2a in 92% yield.
Example 3
Under the protection of nitrogen, Pd2(dba)3(1.8 mg, 0.002 mmol, 1 mol%) and potassium hydride (30% in oil, 133 mg, 1.0 mmol, 5 equiv) were suspended in THF (1.0 mL), stirred at room temperature for 5 minutes, a solution of compound 1a (0.2 mmol) in THF (0.5 mL) was added, followed by reaction at-50 ℃ for 10 hours, a saturated aqueous solution of ammonium chloride was added to terminate the reaction, extraction was performed with ethyl acetate, the combined extracts were dried over sodium sulfate, rotary evaporated to dryness, and purified by column chromatography to give product 2a in 71% yield.
Example 4
Pd (TFA) under nitrogen protection2(67 mg, 0.2 mmol, 100 mol%) and calcium hydride (16 mg, 0.4 mmol, 2.0 equiv) were suspended in DME (1.0 mL), stirred at room temperature for 5 minutes, added with a solution of Compound 1a (0.2 mmol) in DME (0.5 mL), reacted at 90 ℃ for 0.5 hour, quenched with saturated aqueous ammonium chloride, extracted with ethyl acetate, combined extracts, and washed with sodium sulfateDrying, rotary evaporation and evaporation to dryness, and purifying by column chromatography to obtain the product 2a with the yield of 83%.
Example 5
Under the protection of nitrogen, [ (eta ]3-C3H5)PdCl]2(1.4 mg, 0.004 mmol, 2 mol%) and sodium hydride (60% in oil, 8 mg, 0.20 mmol, 1.0 equiv) were suspended in dioxane (1.0 mL), stirred at room temperature for 5 minutes, a solution of compound 1a (0.2 mmol) in dioxane (0.5 mL) was added, then reacted at 30 ℃ for 2 hours, a saturated aqueous ammonium chloride solution was added to stop the reaction, extracted with ethyl acetate, the extracts were combined, dried over sodium sulfate, rotary evaporated to dryness, and purified by column chromatography to give product 2a in 69% yield.
Example 6
Pd/C (10%, 0.01 mmol, 5 mol%) and sodium hydride (60% in oil, 16 mg, 0.4 mmol, 2 equiv) were suspended in DMA (1.0 mL) under nitrogen, stirred at room temperature for 5 minutes, a solution of compound 1a (0.2 mmol) in DMA (0.5 mL) was added, then reacted at room temperature for 10 hours, saturated aqueous ammonium chloride was added to quench the reaction, extracted with ethyl acetate, the combined extracts were dried over sodium sulfate, rotary evaporated to dryness, purified by column chromatography to give product 2a in 8% yield.
Example 7
Pd (dppp) Cl under nitrogen protection2(6 mg, 0.01 mmol, 5 mol%) and sodium hydride (60% in oil, 16 mg, 0.4 mmol, 2 equiv) were suspended in DMA (1.0 mL), stirred at room temperature for 5 minutes, a solution of Compound 1a (0.2 mmol) in DMA (0.5 mL) was added, then reacted at room temperature for 1 hour, and saturated aqueous ammonium chloride was added to terminate the reactionExtracting with ethyl acetate, combining the extracts, drying with sodium sulfate, rotary-steaming to dryness, and purifying by column chromatography to obtain the product 2a with yield of 57%.
Example 8
Pd (C) under nitrogen protection6H5CN)2Cl2(3.8 mg, 0.01 mmol, 5 mol%) and sodium hydride (60% in oil, 16 mg, 0.4 mmol, 2 equiv) were suspended in DMA (1.0 mL), stirred at room temperature for 5 minutes, a solution of compound 1a (0.2 mmol) in DMA (0.5 mL) was added, then reacted at room temperature for 1 hour, a saturated aqueous ammonium chloride solution was added to terminate the reaction, extracted with ethyl acetate, the combined extracts were dried over sodium sulfate, rotary evaporated to dryness, and purified by column chromatography to give product 2a in 62% yield.
Example 9
Under the protection of nitrogen, Pd (OH)2(1.4 mg, 0.01 mmol, 5 mol%) and sodium hydride (60% in oil, 16 mg, 0.4 mmol, 2 equiv) were suspended in DMA (1.0 mL), stirred at room temperature for 5 minutes, a solution of compound 1a (0.2 mmol) in DMA (0.5 mL) was added, followed by reaction at room temperature for 0.5 hour, saturated aqueous ammonium chloride solution was added to terminate the reaction, extraction was performed with ethyl acetate, the combined extracts were dried over sodium sulfate, rotary evaporated to dryness, and purified by column chromatography to give product 2a in 71% yield.
Example 10
Palladium chloride (1.7 mg, 0.01 mmol, 5 mol%) and sodium hydride (60% in oil, 16 mg, 0.4 mmol, 2 equiv) were suspended in DMA (1.0 mL) under nitrogen, stirred at room temperature for 5 minutes, added with a solution of compound 1b (0.2 mmol) in DMA (0.5 mL), and then at room temperatureReacting for 30 minutes, adding saturated ammonium chloride aqueous solution to stop the reaction, extracting with ethyl acetate, combining extract liquor, drying with sodium sulfate, rotary-steaming to dryness, and purifying by column chromatography to obtain a product 2b with the yield of 98%.1H NMR (400 MHz, CDCl3): δ 7.49 (t, J = 7.6 Hz, 2H), 7.39 (t, J = 7.4 Hz, 1H), 7.22 (d, J = 7.6 Hz, 2H), 7.19-7.11 (m, 2H), 7.03-6.96 (m, 2H), 6.80-6.74 (m, 2H), 6.69-6.64 (m, 2H), 3.97-3.88 (m, 1H), 3.69 (s, 3H), 3.51 (dd, J= 13.5, 4.1 Hz, 1H), 3.13 (dd, J = 13.4, 8.4 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 176.56, 159.52, 144.52, 138.98, 134.57, 129.71, 129.30, 128.28, 128.19, 128.00, 126.78, 124.87, 122.64, 122.14, 114.69, 112.86, 109.34, 55.26, 47.28, 37.34. LR-MS (ESI): m/z 330.2 [M+H]+。
Example 11
Palladium chloride (1.7 mg, 0.01 mmol, 5 mol%) and sodium hydride (60% in oil, 16 mg, 0.4 mmol, 2 equiv) were suspended in DMA (1.0 mL) under nitrogen, stirred at room temperature for 5 minutes, a solution of compound 1c (0.2 mmol) in DMA (0.5 mL) was added, then reacted at room temperature for 30 minutes, saturated aqueous ammonium chloride was added to quench the reaction, extracted with ethyl acetate, the combined extracts were dried over sodium sulfate, evaporated to dryness by rotary evaporation, and purified by column chromatography to give product 2c in 98% yield.1H NMR (400 MHz, CDCl3): δ 7.49 (t, J = 7.5 Hz, 2H), 7.38 (t, J = 7.3 Hz, 1H), 7.31 (d, J = 7.7 Hz, 2H), 7.25-7.17 (m, 2H), 7.12 (t, J = 7.6 Hz, 1H), 7.08-6.91 (m, 3H), 6.89 (d, J = 7.2 Hz, 1H), 6.69 (d, J = 7.8 Hz, 1H), 3.98-3.90 (m, 1H), 3.60 (dd, J = 13.8, 5.0 Hz, 1H), 3.12 (dd, J = 13.7, 8.4 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 176.44, 161.37 (d, J = 246.0 Hz), 144.30, 134.59, 131.76 (d, J = 4.5 Hz), 129.72, 128.72 (d, J = 8.1 Hz), 128.18, 128.04, 127.94, 126.74, 125.07, 124.92, 124.02 (d, J = 3.6 Hz), 122.69, 115.47 (d, J = 22.2 Hz), 109.26, 46.05, 30.26. LR-MS (ESI): m/z 318.3 [M+H]+。
Example 12
Palladium chloride (1.7 mg, 0.01 mmol, 5 mol%) and sodium hydride (60% in oil, 16 mg, 0.4 mmol, 2 equiv) were suspended in DMA (1.0 mL) under nitrogen, stirred at room temperature for 5 minutes, a solution of compound 1d (0.2 mmol) in DMA (0.5 mL) was added, then reacted at room temperature for 1 hour, saturated aqueous ammonium chloride was added to quench the reaction, extracted with ethyl acetate, the combined extracts were dried over sodium sulfate, evaporated to dryness by rotary evaporation, and purified by column chromatography to give product 2d in 97% yield.1H NMR (400 MHz, CDCl3): δ 7.84-7.77 (m, 1H), 7.77-7.70 (m, 2H), 7.62 (s, 1H), 7.49-7.41 (m, 4H), 7.40-7.31 (m, 2H), 7.20 (d, J = 7.5 Hz, 2H), 7.14-7.07 (m, 1H), 6.97-6.91 (m, 2H), 6.64 (d, J = 7.8 Hz, 1H), 4.02 (dd, J = 8.2, 4.4 Hz, 1H), 3.70 (dd, J = 13.6, 4.3 Hz, 1H), 3.32 (dd, J = 13.6, 8.4 Hz, 1H). 13C NMR (151 MHz, CDCl3): δ 176.60, 144.44, 135.12, 134.54, 133.44, 132.46, 129.68, 128.31, 128.20, 128.15, 128.01, 127.96, 127.87, 127.77, 127.71, 126.74, 126.09, 125.67, 124.88, 122.65, 109.36, 47.28, 37.41. LR-MS (ESI): m/z 350.2 [M+H]+。
Example 13
Palladium chloride (1.7 mg, 0.01 mmol, 5 mol%) and sodium hydride (60% in oil, 16 mg, 0.4 mmol, 2 equiv) were suspended in DMA (1.0 mL) under nitrogen, stirred at room temperature for 5 minutes, a solution of compound 1e (0.2 mmol) in DMA (0.5 mL) was added, then reacted at room temperature for 30 minutes, saturated aqueous ammonium chloride was added to stop the reaction, extracted with ethyl acetate, the extracts were combined, and sulfuric acid was used to prepare a solutionSodium drying, rotary evaporation to dryness, and column chromatography purification to obtain product 2e with 98% yield.1H NMR (400 MHz, CDCl3): δ 8.86 (d, J = 4.1 Hz, 1H), 8.27 (d, J = 8.3 Hz, 1H), 8.20 (d, J = 8.4 Hz, 1H), 7.76 (t, J = 7.5 Hz, 1H), 7.63 (t, J = 7.5 Hz, 1H), 7.53 (t, J = 7.6 Hz, 2H), 7.42 (t, J = 7.3 Hz, 1H), 7.35 (d, J = 7.7 Hz, 2H), 7.31 (d, J = 4.1 Hz, 1H), 7.16 (t, J = 7.7 Hz, 1H), 6.91 (t, J = 7.5 Hz, 1H), 6.77 (d, J = 7.9 Hz, 1H), 6.71 (d, J = 7.3 Hz, 1H), 4.16-4.02 (m, 2H), 3.36 (dd, J = 13.5, 9.5 Hz, 1H). 13C NMR (151 MHz, CDCl3): δ 176.17, 149.67, 148.34, 144.70, 144.23, 134.37, 130.28, 129.80, 129.74, 128.37, 128.35, 127.85, 127.44, 127.11, 126.65, 124.99, 123.76, 122.82, 122.47, 109.67 , 45.71, 34.03. LR-MS (ESI): m/z 351.1 [M+H]+。
Example 14
Palladium chloride (1.7 mg, 0.01 mmol, 5 mol%) and sodium hydride (60% in oil, 16 mg, 0.4 mmol, 2 equiv) were suspended in DMA (1.0 mL) under nitrogen, stirred at room temperature for 5 minutes, a solution of compound 1f (0.2 mmol) in DMA (0.5 mL) was added, then reacted at room temperature for 30 minutes, saturated aqueous ammonium chloride was added to quench the reaction, extracted with ethyl acetate, the combined extracts were dried over sodium sulfate, evaporated to dryness by rotary evaporation, and purified by column chromatography to give product 2f (Diastereomer a/b = 58/42) in 96% yield. Diastereomer a: 1H NMR (400 MHz, CDCl3): δ 7.46 (t, J = 7.6 Hz, 2H), 7.36 (t, J = 7.4 Hz, 1H), 7.32-7.17 (m, 7H), 7.09 (t, J = 7.6 Hz, 1H), 6.89 (t, J = 7.4 Hz, 1H), 6.69-6.60 (m, 2H), 3.88-3.84 (m, 1H), 3.83-3.77 (m, 1H), 1.31 (d, J = 7.0 Hz, 3H). 13C NMR (151 MHz, CDCl3): δ 176.26, 144.85, 142.41, 134.63, 129.71, 128.34, 128.17, 128.06, 127.95, 126.85, 126.77, 126.66, 125.05, 122.46, 109.12, 52.58, 40.72, 14.32. Diastereomer b: 1H NMR (400 MHz, CDCl3): δ 7.40 (t, J = 7.4 Hz, 2H), 7.34 (d, J = 7.2 Hz, 2H), 7.18-7.09 (m, 4H), 7.05 (t, J = 7.4 Hz, 1H), 6.98 (d, J = 6.6 Hz, 2H), 6.92 (d, J = 7.5 Hz, 2H), 6.51 (d, J = 7.7 Hz, 1H), 3.79 (d, J = 4.4 Hz, 1H), 3.75-3.65 (m, 1H), 1.69 (d, J = 7.2 Hz, 3H). 13C NMR (151 MHz, CDCl3): δ 176.24, 144.97, 141.21, 134.45, 129.61, 128.25, 128.14, 128.11, 127.90, 127.03, 126.97, 126.85, 125.23, 122.37, 109.22, 52.49, 42.51, 19.22. LR-MS (ESI): m/z 314.2 [M+H]+。
example 15
Palladium chloride (1.7 mg, 0.01 mmol, 5 mol%) and sodium hydride (60% in oil, 16 mg, 0.4 mmol, 2 equiv) were suspended in DMA (1.0 mL) under nitrogen, stirred at room temperature for 5 minutes, a solution of compound 1g (0.2 mmol) in DMA (0.5 mL) was added, then reacted at room temperature for 30 minutes, saturated aqueous ammonium chloride was added to quench the reaction, extracted with ethyl acetate, the combined extracts were dried over sodium sulfate, evaporated to dryness by rotary evaporation, and purified by column chromatography to give 2g of product in 98% yield.1H NMR (400 MHz, CDCl3): δ 7.52 (t, J = 7.6 Hz, 2H), 7.44-7.31 (m, 4H), 7.20 (t, J = 7.7 Hz, 1H), 7.08 (t, J = 7.4 Hz, 1H), 6.79 (d, J = 7.8 Hz, 1H), 3.55 (d, J = 2.7 Hz, 1H), 2.66-2.54 (m, 1H), 1.18 (d, J = 7.0 Hz, 3H), 0.97 (d, J = 6.8 Hz, 3H). 13C NMR (151 MHz, CDCl3): δ 176.91, 144.85, 134.72, 129.70, 128.09, 127.81, 127.67, 126.77, 124.73, 122.64, 109.22, 51.76, 31.48, 19.90, 18.06. LR-MS (ESI): m/z 252.2 [M+H]+。
Claims (3)
1. The application of a metal hydride/palladium compound catalytic reduction system in the reduction of an alkenyl active methylene compound; the chemical structural formula of the alkenyl active methylene compound is as follows:
wherein R is1、R2Independently selected from hydrogen, alkyl, phenyl, substituted phenyl, naphthyl, pyridyl and quinolyl;
the metal hydride is sodium hydride, lithium hydride, potassium hydride or calcium hydride; the palladium compound is palladium chloride, palladium acetate, Pd (dppp) Cl2Or Pd (OH)2。
2. The use of claim 1, wherein the molar ratio of the palladium compound, the metal hydride and the alkenyl-active methylene compound is (0.01-1) to (1-5) to 1.
3. The use according to claim 1, wherein the reduction of the alkenyl-activated methylene compound is carried out in a solvent under a nitrogen atmosphere; the reduction temperature of the alkenyl active methylene compound is-50 ℃ to 120 ℃, and the reduction time is 0.3 to 10 hours.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811064127.4A CN109020864B (en) | 2018-09-12 | 2018-09-12 | Application of metal hydride/palladium compound catalytic reduction system in reduction of alkenyl active methylene compound and reduction method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811064127.4A CN109020864B (en) | 2018-09-12 | 2018-09-12 | Application of metal hydride/palladium compound catalytic reduction system in reduction of alkenyl active methylene compound and reduction method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109020864A CN109020864A (en) | 2018-12-18 |
CN109020864B true CN109020864B (en) | 2021-05-28 |
Family
ID=64621341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811064127.4A Active CN109020864B (en) | 2018-09-12 | 2018-09-12 | Application of metal hydride/palladium compound catalytic reduction system in reduction of alkenyl active methylene compound and reduction method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109020864B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020051853A1 (en) * | 2018-09-13 | 2020-03-19 | 南通纺织丝绸产业技术研究院 | 3,3-disubstituted oxindole and preparation method thereof |
WO2020051854A1 (en) * | 2018-09-13 | 2020-03-19 | 南通纺织丝绸产业技术研究院 | Use of metal hydride/palladium compound catalytic reduction system in reduction of alkenyl active methylene compound and reduction method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106316923A (en) * | 2015-08-21 | 2017-01-11 | 中南大学 | Disubstituted indol-2(1H)-one derivative and preparation method and application thereof |
CN108218672A (en) * | 2018-01-30 | 2018-06-29 | 苏州大学 | Application of the metal compound/palladium compound catalytic reduction system in de- allyl reaction and deuterated reaction |
CN108358760A (en) * | 2018-01-30 | 2018-08-03 | 苏州大学 | Application of the metal compound/palladium compound catalytic reduction system in debenzylation and deuterated reaction |
-
2018
- 2018-09-12 CN CN201811064127.4A patent/CN109020864B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106316923A (en) * | 2015-08-21 | 2017-01-11 | 中南大学 | Disubstituted indol-2(1H)-one derivative and preparation method and application thereof |
CN108218672A (en) * | 2018-01-30 | 2018-06-29 | 苏州大学 | Application of the metal compound/palladium compound catalytic reduction system in de- allyl reaction and deuterated reaction |
CN108358760A (en) * | 2018-01-30 | 2018-08-03 | 苏州大学 | Application of the metal compound/palladium compound catalytic reduction system in debenzylation and deuterated reaction |
Non-Patent Citations (7)
Title |
---|
3-Substituted, 3-(4-Pyridinylmethyl)1- ,3-dihydro-l-phenyl-2H-indol-2-ones as Acetylcholine Release Enhancers: Synthesis and SAR;Wendell W. Wilkerson,等;《J. Med. Chem.》;19931231;第36卷;2899-2907 * |
C-3 alkylation of oxindole with alcohols by Pt/CeO2 catalyst in additive-free conditions;Chandan Chaudhari,等;《Catal. Sci. Technol》;20141231;第4卷;1064-1069 * |
N-Phenyl-2-indolinones and N-Phenylindolines. A New Class of Antidepressant Agents;A. Cañas-Rodriguez,等;《Journal of Medicinal Chemistry》;19721231;第15卷(第7期);762-770 * |
RN:1033200-47-3;STN-REGISTRY;《RN:1033200-47-3》;20080709 * |
RN:1033201-73-8;STN-REGISTRY;《RN:1033201-73-8》;20080709 * |
Synthesis of 3-[4-(dimethylamino)phenyl]alkyl-2-oxindole derivatives and their effects on neuronal cell death;Kyoji Furuta,等;《Bioorganic & Medicinal Chemistry Letters》;20171231;第27卷(第18期);4457-4461 * |
Use of reductive properties of iodotrichlorosilane II: Chemoselective reduction of α,β-unsaturated ketones and nitriles;Saad S. Elmorsy,等;《Tetrahedron Letters》;19961231;第37卷(第13期);2297-2298 * |
Also Published As
Publication number | Publication date |
---|---|
CN109020864A (en) | 2018-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112174782B (en) | Application of metal deuteride/palladium compound catalytic reduction system in deuteration reaction | |
CN108358760B (en) | Application of metalate/palladium compound catalytic reduction system in debenzylation reaction and deuteration reaction | |
CN109020864B (en) | Application of metal hydride/palladium compound catalytic reduction system in reduction of alkenyl active methylene compound and reduction method | |
CN109369661B (en) | Method for synthesizing chiral hydrogenated benzofuran compound by (3 + 2) cycloaddition dearomatization | |
CN115368272A (en) | Preparation method of 4-cyano-2-methoxybenzaldehyde | |
CN109053446B (en) | Application of metal hydride/palladium compound system in preparation of 1, 3-dicarbonyl compound by series reaction of electron-deficient alkene compound | |
CN110003011B (en) | Preparation method of nitroolefin derivative by taking nitrate as nitro source | |
CN109761897B (en) | Method for copper-catalyzed alkylation of C (sp2) -H bond of N-heterocyclic aromatic hydrocarbon compound | |
CN108976122B (en) | Method for producing 1, 3-dicarbonyl compounds based on metal hydride/palladium compound systems | |
CN109096105B (en) | Reduction method of alkenyl active methylene compound and reduction product | |
CN112574081B (en) | Process for preparing arylthioamide compounds | |
CN111592507A (en) | Novel green and simple method for preparing polysubstituted furan | |
US11420925B2 (en) | Reduction method and reduction product of alkenyl active methylene compound | |
CN109020865B (en) | 3, 3-disubstituted oxindole and preparation method thereof | |
CN115806543A (en) | Articaine hydrochloride intermediate and preparation method and application thereof | |
WO2020051853A1 (en) | 3,3-disubstituted oxindole and preparation method thereof | |
US20210206708A1 (en) | Method for preparing 1,3-dicarbonyl compound based on metal hydride/palladium compound system | |
CN108976198B (en) | Synthetic method of 3- (4-pyridine) indole compound | |
WO2020051854A1 (en) | Use of metal hydride/palladium compound catalytic reduction system in reduction of alkenyl active methylene compound and reduction method | |
CN107176965B (en) | Novel method for synthesizing abiraterone acetate | |
CN111320622A (en) | Method for synthesizing moxifloxacin hydrochloride | |
CN112142728B (en) | Imazethapyr intermediate and synthesis method and application thereof | |
CN114890942A (en) | 3-bromo-6-chloropyridine-2-formic acid and preparation method thereof | |
CN109608459B (en) | Synthetic method of nitrogen-containing heterocyclic quaternary salt compound | |
WO2020056565A1 (en) | Application of metal hydride/palladium compound system in preparation of 1,3-dicarbonyl compound in cascade reaction of electron-deficient alkene compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |